boldione
โ Previous: boldenone | ๐ All Substances | ๐ Complete Table | Next: BPC-157 โ
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Reason | Controlled substance: Schedule III |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents) |
| Added to Database | December 30, 2025 |
| Source Last Updated | May 28, 2024 |
| GUID | 6418095e-8272-4873-ac45-cb8101f4fe8b |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 2166Q8568W ยท CAS: 897-06-3
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C19H24O2 |
| Molecular Weight | 284.4 g/mol |
| IUPAC Name | (8R,9S,10R,13S,14S)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione |
| InChIKey | LUJVUUWNAPIQQI-QAGGRKNESA-N |
๐ Complete Table | ๐ All Substances
Substance 231 of 880